Significant hypophosphayemia (SH) may be associated with respiratory and cardiac complications but has not been targeted as a reversible cause of these complications following cardiac surgery.

Patients and methods
====================

We prospectively studied all patients (*n*= 566, males 388, females 178, mean age 65.5 \[11.1\] years) undergoing major cardiac surgery (coronary artery bypass grafting \[CABG\] 75.4%; aortic valve replacement 5.1%; aortic valve replacement + CABG 5.8%; mitral valve replacement 6.8%; other 6.9%) over a 6-month period. Phosphate levels were measured preoperatively, on admission to the ICU, and on the first postoperative day. Two groups were defined according to the ICU admission level: SH, level \<0.48 mmol/l; and a control group, normal range 0.8--1.45 mmol/l. Preoperative, intraoperative and postoperative data were collected in all patients. SH was treated with intravenous sodium or potassium phosphate (0.08 mmol/kg) over 6--12 hours.

Results
=======

SH was found in 34.3% (mean level 0.29 \[0.13\] vs 0.84 \[0.11\]). Preoperative data are presented in Table [1](#T1){ref-type="table"}, and the postoperative course in Table [2](#T2){ref-type="table"}. The phosphate level tended to be lower in the SH group on the first postoperative day (0.6 \[0.15\] vs 0.81 \[0.10\]), suggesting inadequate repletion.

  Parameter           SH (*n*= 194)   Control (*n*= 372)   *P*value
  ------------------- --------------- -------------------- ----------
  Risk score          17.9 (12.1)     16.1 (10.9)          NS
  Bypass (min)        117.4 (21.4)    110.5 (12.8)         NS
  Cross-clamp (min)   59.1 (10.9)     55.3 (13.3)          NS
  Units blood         2.2 (1.1)       1.8 (0.9)            0.05
  Units platelets     6.2 (2.4)       2.1 (1.3)            0.01

  Parameter                 SH (*n*= 194)   Control (*n*= 372)   *P*value
  ------------------------- --------------- -------------------- ----------
  Ventilation (days)        2.1 (1.7)       1.1 (0.9)            0.05
  Atrial fibrillation (%)   28.4            31.1                 NS
  ICU stay (days)           2.6 (2.9)       2.1 (2.7)            NS
  Inotrope use (%)          16              10.9                 0.05
  Hospital stay (days)      7.8 (3.4)       5.6 (2.5)            0.05
  Mortality (%)             5.2             4.6                  NS

Conclusions
===========

As SH after cardiac surgery appears to be common and associated with major morbidity, levels should be routinely monitored.
